Cayenne Medical is a Scottsdale, Ariz.-based maker of medical devices used in knee and shoulder reconstruction surgeries. Its Quattro GL suture anchor received FDA 510(k) clearance in August 2013. According to a regulatory filing, the company is nearing a $6 million fundraising goal and is $1 million short of that target. Nine unnamed investors have contributed a collective $5 million through an equity and options sale, per the filing. The filing does not name the investors or provide additional financial details. No revenue, user metrics, past rounds, or founding year are disclosed in the article. Cayenne Medical is a privately held medical device company based in Scottsdale, Arizona, founded in 2005. The company develops soft-tissue reconstruction products for knee ligament reconstruction and meniscal repair, including the AperFix II, CrossFix II and iFix systems, and recently launched the Quattro Shoulder System for rotator cuff and labral repairs. Cayenne focuses on applying advanced technology through minimally invasive techniques to transform traditional soft tissue repair procedures. The company is backed by Split Rock Partners, Investor Growth Capital, Fletcher Spaght Ventures and Memphis Biomed Ventures. Management said it recently completed an equity financing and sought additional debt to provide capacity to invest in sales and marketing and fund working capital. The new financing is intended to strengthen the balance sheet and support commercialization and growth of its product portfolio. Cayenne Medical is a private sports medicine device company based in Scottsdale, Arizona, founded in 2005 and led by President and CEO David Springer. It develops and markets systems for knee ligament reconstruction and meniscal repair, including the AperFix II System, the CrossFix II System and the iFix System. The company is launching the Quattro Shoulder System for rotator cuff and labral repairs. Cayenne recently closed a $10M equity financing to support growth. Proceeds will be used to enhance sales and distribution and to expand its portfolio of sports medicine orthopedic solutions. Investors in the round include new investor Fletcher Spaght Ventures alongside existing backers Split Rock Partners, MB Venture Partners and Investor Growth Capital.

Total raised

$23M

Funding rounds

3

Latest round

Equity

Latest activity

Feb 2014